Competition from less expensive weight-loss drugs has prompted Danish drugmaker Novo Nordisk A/S to announce cuts to pricing for GLP-1 products Wegovy and Ozempic. Novo’s GLP-1s will cost $675 a month across the board, down …
Hormel is riding the protein boom and snack as meals craze, doubling down on value and global flavors. With AI insights and a premium to budget portfolio, the processor is aggressively positioning itself for fragmented, omnichannel consumers.
Federal regulators are stepping back just as wearable platforms gain predictive capabilities. That combination could reshape product formulation, marketing claims, and compliance strategy across the F&B industry.
Microplastics are infiltrating global food systems, raising concerns about human health as exposure grows through packaging, water, and processed foods. Research suggests dietary fiber may help reduce risks.
